Doctors’ and Patients’ Preferences for Participation and Treatment in Curative Prostate Cancer Radiotherapy Immunohistochemistry results for HLA class II were evaluated in 292 primary cHL patients in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback